- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Nectar Lifesciences Limited — Updates, 03-03-2026: General Updates
03-03-2026 | 11:03 am
03-03-2026 | 11:03 am
Nectar Lifesciences' board approved infusing up to 120 Cr as an inter-corporate loan to its upcoming wholly-owned subsidiary, Avensis Exports, after its acquisition. This capital deployment will support the new entity.
No comments yet. Be the first to comment!